{
    "symbol": "GEHC",
    "quarter": 4,
    "year": 2022,
    "date": "2023-02-01 20:34:03",
    "content": " Your line is open. Your line is open. I would start first with saying, yes, I think one of the really interesting things that we\u00e2\u0080\u0099re excited about strategically is we\u00e2\u0080\u0099re the only company out there that actually makes the fuels for molecular imaging as well as has the devices that capture to create the images themselves. Your line is open. Your line is open. Your line is open. Your line is open. Pete and I spent a lot of time with our M&A team to look at opportunities because I think it\u00e2\u0080\u0099s important for us to see what is out there and make sure that we have a good transparency and visibility and then make decisions that are going to be very disciplined for such acquisitions if they fit into our portfolio and AI accretive both at the top line growth, but also from a profitability perspective. Your line is open. Your line is open. We\u00e2\u0080\u0099re also investing in innovative new services, whether they be different types of remote capabilities, Again, when you think about the brake fix side of our business, these are highly valuable products that being down for half a day or a day can wipe out a lot of profits for the institution. Your line is open. The emphasis on innovative products in high-growth areas, many we talked about today, we delivered strong organic revenue growth and sequential margin improvement in the fourth quarter and we expect to capitalize on robust demand in 2023, as we execute on our revenue drivers across each of our segments."
}